Lornoxicam and Paracetamol Tablet

Available Composition of

Lornoxicam and Paracetamol Tablet
NameStrengthTherapeutic useView More
Lornoxicam Tablet4 mg, 8 mg, , ,
Lornoxicam and Paracetamol Tablet4 mg + 325 mg, 4 mg + 500 mg, 8 mg + 325 mg, 8 mg + 500 mg,
Thiocolchicoside Aceclofenac and Paracetamol Tablet4 mg + 100 mg + 325 mg, ,
Ibuprofen and Paracetamol Suspension100 mg + 125 mg, 100 mg + 150 mg,100 mg + 250 mg, 200 mg + 250 mg, , , ,
Paracetamol, Cetirizine, and Phenylephrine Tablet325 mg + 5 mg + 10 mg,
Paracetamol and Promethazine Suspension125 mg + 5 mg, ,
Paracetamol and Dicyclomine Tablet250 mg + 20 mg, 325 mg + 20 mg, 500 mg + 20 mg, ,
Paracetamol and Caffeine Tablet500 mg + 25 mg, 650 mg + 50 mg, ,
Paracetamol Tablet250 mg, 500 mg, 650 mg, 1000 mg,
Paracetamol Suspension100 mg/5ml, 250 mg/5ml
Diclofenac, Paracetamol and Serratiopeptidase Tablet50 mg + 325 mg +15 mg / 50 mg + 50 mg + 10 mg
Diclofenac, Paracetamol and Chlorzoxazone Tablet50mg + 325mg + 250mg, ,
Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablet50 mg + 325 mg+ 250 mg, ,
Diclofenac Potassium, Paracetamol, Chlorzoxazone Tablet50 mg + 325 mg + 250 mg, , ,
Mefenamic Acid and Paracetamol Suspension100 mg / 5 ml + 250 mg / 5ml, 50 mg / 5ml + 125mg / 5ml, ,
Mefenamic Acid and Paracetamol Tablet, ,

Product Description For Lornoxicam and Paracetamol Tablet

products details and uses

Lornoxicam and Paracetamol Tablet Exporter, Manufacturer and Global Supplier in India

Lornoxicam and Paracetamol Tablet Exporter, as a globally recognized we ensure that every batch of this medicine is manufactured under WHO-GMP and ISO-certified facilities, meeting the highest international quality standards. The combination of Lornoxicam, a potent non-steroidal anti-inflammatory drug (NSAID), and Paracetamol (Acetaminophen), a reliable analgesic and antipyretic, delivers comprehensive symptom control for acute and chronic pain conditions. The Lornoxicam and Paracetamol Tablet is a clinically effective formulation that provides dual-action relief from pain and inflammation.

As a leading Lornoxicam and Paracetamol Tablet Exporter, we supply this medication to hospitals, pharmacies, and distributors across Asia, Africa, the Middle East, and Latin America. Our production facilities maintain strict quality protocols to ensure consistency, safety, and efficacy in every dosage form. This combination is widely recommended by healthcare professionals for its superior tolerability and faster onset of pain relief compared to standard analgesics.

Composition and Mechanism of Action

Each Lornoxicam and Paracetamol Tablet typically contains:

  • Lornoxicam (4mg or 8mg)

  • Paracetamol (325mg or 500mg)

Lornoxicam acts by inhibiting the cyclooxygenase (COX) enzymes responsible for prostaglandin synthesis, thereby reducing inflammation and associated pain. Paracetamol complements this effect by inhibiting central pain mediators and lowering elevated body temperature. This synergistic mechanism ensures rapid and sustained relief with minimal gastrointestinal irritation.

As a reputed Lornoxicam and Paracetamol Tablet Exporter, we ensure that our formulation maintains the optimal balance of efficacy and safety, making it suitable for long-term use under medical supervision.

Uses and Indications

The Lornoxicam and Paracetamol Tablet is used to manage a wide range of painful and inflammatory conditions, including:

  • Musculoskeletal pain and joint disorders

  • Osteoarthritis and rheumatoid arthritis

  • Toothache and post-dental surgery pain

  • Back pain, sprains, and strains

  • Post-operative or post-traumatic inflammation

  • Headaches and fever associated with mild infections

Healthcare professionals frequently prefer this tablet for its quick onset of action and lower incidence of gastric side effects compared to other NSAIDs.

Being a reliable Lornoxicam and Paracetamol Tablet Exporter, we cater to large-scale medical institutions, government tenders, and private distributors globally.

Precautions and Warnings

Before using this medication, patients should consult a healthcare provider, especially if they:

  • Have a history of liver, kidney, or gastrointestinal disorders

  • Are pregnant or breastfeeding

  • Have asthma, ulcers, or bleeding disorders

  • Consume alcohol regularly or take other hepatotoxic drugs

Overuse of Paracetamol may lead to liver damage, while prolonged NSAID therapy can increase the risk of gastrointestinal discomfort or renal impairment. Therefore, dosage should be strictly followed as prescribed by a physician.

As a dedicated Lornoxicam and Paracetamol Tablet Exporter, we provide detailed product literature and safety data sheets with each shipment to ensure correct usage by medical professionals.

Possible Side Effects

Common side effects may include:

  • Nausea, vomiting, or stomach discomfort

  • Mild dizziness or headache

  • Indigestion or heartburn

  • Rare allergic reactions such as rash or itching

Serious but uncommon reactions may include liver enzyme elevation, ulceration, or gastrointestinal bleeding if taken without supervision. In such cases, immediate medical attention is recommended.

Why Choose Us as Your Lornoxicam and Paracetamol Tablet Exporter

We stand as a trusted Lornoxicam and Paracetamol Tablet Exporter with a strong reputation for quality, reliability, and global compliance. Our packaging ensures product stability during transit, while our flexible contract manufacturing and private labeling services support custom branding needs.

With proven expertise in pharmaceutical formulation, timely delivery, and transparent business ethics, we continue to serve as a dependable partner to clients seeking premium-grade Lornoxicam and Paracetamol Tablets for domestic and international markets.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Lornoxicam and Paracetamol Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.